The evolving paradigm in management of Multiple Myeloma

Cancer care in Needle Hospital, Hargeisa, Somaliland

The evolving paradigm in management of Multiple Myeloma

Multiple myeloma (A cancer arising from plasma cells)

Multiple myeloma (A cancer arising from plasma cells)

Hope vs Hype of evidence interpretation

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients

Adjuvant radiotherapy has no benefit following radical prostatectomy

Myeloma treatment and prognosis

Management of surgical complications in thyroid surgery

Cost-benefit analysis of new cancer medicines: The difficult choices of governments